Perspective Therapeutics Announces $175M Underwritten Offering of Common Stock

Perspective Therapeutics announced the pricing of a $175 million underwritten offering of common stock and pre-funded warrants. The offering consisted of 39.6 million shares of common stock at $3.79 per share and 6.6 million pre-funded warrants to purchase common stock at $3.789 per warrant. The gross proceeds from the offering are expected to be approximately $175 million, before deducting underwriting discounts and commissions, and other offering expenses.